Rare mucosal lichen planus

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:254373
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Rare mucosal lichen planus is an uncommon variant of lichen planus that predominantly affects the mucosal surfaces of the body, including the oral mucosa, esophageal mucosa, genital mucosa, and occasionally other mucosal sites such as the conjunctiva, nasal passages, and larynx. Lichen planus is a chronic inflammatory condition mediated by T-lymphocytes that target the epithelial basal layer, leading to tissue damage and characteristic clinical findings. In the mucosal form, patients typically present with painful erosions, ulcerations, white reticular (lace-like) patches known as Wickham striae, erythematous areas, and desquamative lesions on affected mucosal surfaces. Oral involvement is the most common presentation, often affecting the buccal mucosa, tongue, and gingiva, and can significantly impair eating, drinking, and oral hygiene. The condition can be debilitating due to chronic pain, difficulty swallowing (when the esophagus is involved), and sexual dysfunction (when genital mucosa is affected). A particularly severe presentation involving multiple mucosal sites is sometimes referred to as vulvovaginal-gingival syndrome or plurimucosal lichen planus. Mucosal lichen planus carries a small but recognized risk of malignant transformation to squamous cell carcinoma, particularly in the oral cavity, necessitating long-term surveillance. The exact cause remains unclear, but it is considered an immune-mediated disorder with potential contributions from genetic susceptibility, environmental triggers, and immune dysregulation. Treatment is primarily aimed at controlling symptoms and reducing inflammation, as there is no definitive cure. First-line therapy typically includes topical corticosteroids applied to affected mucosal surfaces. For refractory or severe cases, topical calcineurin inhibitors (such as tacrolimus), systemic corticosteroids, or systemic immunosuppressive agents (such as mycophenolate mofetil, methotrexate, or azathioprine) may be employed. Regular follow-up with multidisciplinary care involving dermatologists, oral medicine specialists, gynecologists, and gastroenterologists is recommended depending on the sites involved.

Also known as:

Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Rare mucosal lichen planus.

View clinical trials →

No actively recruiting trials found for Rare mucosal lichen planus at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Rare mucosal lichen planus community →

No specialists are currently listed for Rare mucosal lichen planus.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Rare mucosal lichen planus.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Rare mucosal lichen planusForum →

No community posts yet. Be the first to share your experience with Rare mucosal lichen planus.

Start the conversation →

Latest news about Rare mucosal lichen planus

No recent news articles for Rare mucosal lichen planus.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Rare mucosal lichen planus

What is Rare mucosal lichen planus?

Rare mucosal lichen planus is an uncommon variant of lichen planus that predominantly affects the mucosal surfaces of the body, including the oral mucosa, esophageal mucosa, genital mucosa, and occasionally other mucosal sites such as the conjunctiva, nasal passages, and larynx. Lichen planus is a chronic inflammatory condition mediated by T-lymphocytes that target the epithelial basal layer, leading to tissue damage and characteristic clinical findings. In the mucosal form, patients typically present with painful erosions, ulcerations, white reticular (lace-like) patches known as Wickham stri

How is Rare mucosal lichen planus inherited?

Rare mucosal lichen planus follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Rare mucosal lichen planus typically begin?

Typical onset of Rare mucosal lichen planus is adult. Age of onset can vary across affected individuals.